A CaCO3-based synergistic immunotherapy strategy for treating primary and distal tumors.
Sign Up to like & getrecommendations! Published in 2023 at "Chemical communications"
DOI: 10.1039/d2cc07076f
Abstract: Low response rate limits the widespread application of cancer immunotherapy. To improve the response rate of immunotherapy, a CaCO3-based composite nanomaterial was developed to induce immunogenic cell death for enhancing immunotherapy against 4T1 primary and… read more here.
Keywords: immunotherapy; distal tumors; synergistic immunotherapy; primary distal ... See more keywords